The way we live has changed, and health, work and wellbeing will never be the same.
What will it take for us – and our employees – to embrace this new world, and to flourish? How can we capitalize on all we’ve learned during the last two years to create a new paradigm for benefits leadership?
From virtual care strategies, care navigation and diverse networks to new approaches to engagement and emotional wellbeing, employers and experts will help you deliver innovative solutions and collaborate with partners in your organization to promote a connected, committed workforce.
Here’s a fast and easy way to understand what the newest info on the pandemic means for you and your employees.
From infection risk and safety measures to the outlook for vaccines and treatments, NEBGH’s medical director breaks it all down for you.
Each Monday at 1 PM – it’s appointment viewing!
Millions of Americans have long COVID according to an extensive study of privately-insured patients by FAIR Health, with many implications for employers over the months and years to come.
FAIR Health’s President Robin Gelburd joins Dr. Mark to talk about who’s at greatest risk, the most common symptoms and the potential impact on patients, families and workplaces.
Most organizations – regardless of industry – have employees that struggle with health-related social needs.
Understanding how SDOH affects your employees – and what you can do to help – is essential to your overall health and well-being strategy. It’s also an important part of DE&I!
Learn what steps you can take now to make an impact – including looking at your data and creating a culture that supports all employees.
Who assesses how well a drug works and the economic value that represents for patients? How is the clinical effectiveness of a drug for a certain condition assessed vs. its competitors - and a “fair price” established?
The Institute for Clinical and Economic Review (ICER) is an independent, nonprofit watchdog on drug pricing.
You’ve asked about ICER – now find out!